Publications by authors named "Liberio Santana"
Background: Breast cancer subtype classification according to hormone receptors (HR) and human epidermal growth factor receptor 2 (HER2) using immunohistochemistry is the standard practice for therapeutic decision making.
Objective: To design future studies information on characteristics and survival of each subtype is essential.
Method: We conducted a retrospective study to analyze clinical and pathologic features as well as survival data according to breast cancer immunohistochemistry subtype.
Article Synopsis
- Breast cancer subtype classification based on hormone receptors (HR) and HER2 is crucial for treatment decisions through immunohistochemistry.
- A retrospective study revealed different survival rates among breast cancer subtypes, showing HR(+)/HER2(-) patients had better overall survival compared to the triple negative subtype.
- Findings suggest that HR positive subtypes are more common and associated with longer survival rates compared to triple negative breast cancer.